Methylenetetrahydrofolate reductase and angiotensin converting enzyme gene polymorphisms in two genetically and diagnostically distinct cohort of Alzheimer patients

[1]  D. Moore,et al.  Preparation and Analysis of DNA , 2002 .

[2]  Sudha Seshadri,et al.  Plasma Homocysteine as a Risk Factor for Dementia and Alzheimer's Disease , 2002 .

[3]  M. Hessner,et al.  Age-dependent prevalence of vascular disease-associated polymorphisms among 2689 volunteer blood donors. , 2001, Clinical chemistry.

[4]  J. Rhodin,et al.  A Vascular Connection to Alzheimer's Disease , 2001, Microcirculation.

[5]  T. Isbir,et al.  Interaction between apolipoprotein-E and angiotensin-converting enzyme genotype in Alzheimer's disease , 2001, American journal of Alzheimer's disease and other dementias.

[6]  B. Winblad,et al.  Vitamin B12 and folate in relation to the development of Alzheimer’s disease , 2001, Neurology.

[7]  G. Zuliani,et al.  Genetic polymorphisms in older subjects with vascular or Alzheimer's dementia , 2001, Acta neurologica Scandinavica.

[8]  J. Kril,et al.  Alzheimer's disease: its diagnosis and pathogenesis. , 2001, International review of neurobiology.

[9]  R. Sulkava,et al.  Cardiovascular risk factors and Alzheimer's disease: a genetic association study in a population aged 85 or over , 2000, Neuroscience Letters.

[10]  D. Easton,et al.  The ACE gene and Alzheimer's disease susceptibility , 2000, Journal of medical genetics.

[11]  R. Duara,et al.  Gender-specific association of the angiotensin converting enzyme gene with Alzheimer's disease , 2000, Neuroscience Letters.

[12]  E. Rogaev,et al.  Association between angiotensin-converting enzyme and Alzheimer disease. , 2000, Archives of neurology.

[13]  V. Álvarez,et al.  Angiotensin converting enzyme and endothelial nitric oxide synthase DNA polymorphisms and late onset Alzheimer's disease , 1999, Journal of neurology, neurosurgery, and psychiatry.

[14]  D. Knook,et al.  Thermolabile methylenetetrahydrofolate reductase gene and the risk of cognitive impairment in those over 85 , 1999, Journal of neurology, neurosurgery, and psychiatry.

[15]  K. Blennow,et al.  The Role of the Polymorphic Genes Apolipoprotein E and Methylene- tetrahydrofolate Reductase in the Development of Dementia of the Alzheimer Type , 1999, Dementia and Geriatric Cognitive Disorders.

[16]  M. L. Fravolini,et al.  Angiotensin converting enzyme deletion allele in different kinds of dementia disorders , 1999, Neuroscience Letters.

[17]  M. Owen,et al.  Variation in DCP1, encoding ACE, is associated with susceptibility to Alzheimer disease , 1999, Nature Genetics.

[18]  R Clarke,et al.  Folate, vitamin B12, and serum total homocysteine levels in confirmed Alzheimer disease. , 1998, Archives of neurology.

[19]  B. Bénéteau-Burnat,et al.  Plasma concentration, kinetic constants, and gene polymorphism of angiotensin I-converting enzyme in centenarians. , 1998, Clinical chemistry.

[20]  J. Selhub,et al.  Relationship between homocysteine and thrombotic disease. , 1998, The American journal of the medical sciences.

[21]  N. Bornstein,et al.  ACE, MTHFR, factor V Leiden, and APOE polymorphisms in patients with vascular and Alzheimer's dementia. , 1998, Stroke.

[22]  L. Donini,et al.  DNA Polymorphisms of Apolipoprotein B and Angiotensin I-Converting Enzyme Genes and Relationships with Lipid Levels in Italian Patients with Vascular Dementia or Alzheimer’s Disease , 1998, Dementia and Geriatric Cognitive Disorders.

[23]  D. Seripa,et al.  Apolipoprotein E Genotype in Sporadic Early- and Late-Onset Alzheimer’s Disease , 1998, Dementia and Geriatric Cognitive Disorders.

[24]  M. Margaglione,et al.  A fast and accurate method for genotyping the angiotensin-converting enzyme I/D polymorphism. , 1998, Circulation.

[25]  V. Gudnason,et al.  C677T (thermolabile alanine/valine) polymorphism in methylenetetrahydrofolate reductase (MTHFR): its frequency and impact on plasma homocysteine concentration in different European populations. EARS group. , 1997, Atherosclerosis.

[26]  H. Markus,et al.  A common polymorphism in the methylenetetrahydrofolate reductase gene, homocysteine, and ischemic cerebrovascular disease. , 1997, Stroke.

[27]  S. Ibayashi,et al.  Polymorphism of the angiotensin-converting enzyme (ACE) gene in patients with thrombotic brain infarction. , 1997, Atherosclerosis.

[28]  T. Raghunathan,et al.  Myocardial infarction in young women in relation to plasma total homocysteine, folate, and a common variant in the methylenetetrahydrofolate reductase gene. , 1997, Circulation.

[29]  M. Margaglione,et al.  Clinical Relevance of Polymorphic Markers of Arterial Thrombosis , 1997, Thrombosis and Haemostasis.

[30]  C. Brayne,et al.  Analysis of alpha-1 antichymotrypsin, presenilin-1, angiotensin-converting enzyme, and methylenetetrahydrofolate reductase loci as candidates for dementia. , 1997, American journal of medical genetics.

[31]  W. Markesbery,et al.  Brain infarction and the clinical expression of Alzheimer disease. The Nun Study. , 1997, JAMA.

[32]  L. Taylor,et al.  Common mutation in methylenetetrahydrofolate reductase. Correlation with homocysteine metabolism and late-onset vascular disease. , 1996, Circulation.

[33]  P. Amouyel,et al.  The deletion allele of the angiotensin I converting enzyme gene as a genetic susceptibility factor for cognitive impairment , 1996, Neuroscience Letters.

[34]  I. Rosenberg,et al.  Relation between folate status, a common mutation in methylenetetrahydrofolate reductase, and plasma homocysteine concentrations. , 1996, Circulation.

[35]  P. Frosst,et al.  Molecular genetic analysis in mild hyperhomocysteinemia: a common mutation in the methylenetetrahydrofolate reductase gene is a genetic risk factor for cardiovascular disease. , 1996, American journal of human genetics.

[36]  F. Cambien,et al.  Angiotensin I converting enzyme gene polymorphism and coronary heart disease. , 1995, European heart journal.

[37]  R Kreutz,et al.  A prospective evaluation of an angiotensin-converting-enzyme gene polymorphism and the risk of ischemic heart disease. , 1995, The New England journal of medicine.

[38]  R. Matthews,et al.  A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase , 1995, Nature Genetics.

[39]  H. Blom,et al.  Thermolabile 5,10-methylenetetrahydrofolate reductase as a cause of mild hyperhomocysteinemia. , 1995, American journal of human genetics.

[40]  L. Tiret,et al.  Plasma Level and Gene Polymorphism of Angiotensin‐Converting Enzyme in Relation to Myocardial Infarction , 1994, Circulation.

[41]  A. McCaddon,et al.  Familial Alzheimer's disease and vitamin B12 deficiency. , 1994, Age and ageing.

[42]  P. Froguel,et al.  Genetic associations with human longevity at the APOE and ACE loci , 1994, Nature Genetics.

[43]  B. Costall,et al.  Angiofensin converting enzyme density is increased in temporal cortex from patients with Alzheimer's disease , 1991 .

[44]  J. Ramsdell,et al.  Nutritional status of free-living Alzheimer's patients. , 1989, The American journal of the medical sciences.

[45]  R. Nixon,et al.  Cerebrospinal fluid levels of angiotensin- converting enzyme, acetylcholinesterase, and dopamine metabolites in dementia associated with Alzheimer's disease and Parkinson's disease: A correlative study , 1986, Biological Psychiatry.

[46]  Z. Khachaturian.  Diagnosis of Alzheimer's disease. , 1985, Archives of neurology.

[47]  G. Boers,et al.  Heterozygosity for homocystinuria in premature peripheral and cerebral occlusive arterial disease. , 1985, The New England journal of medicine.

[48]  R. Nixon,et al.  Cerebrospinal fluid levels of angiotensin-converting enzyme in Alzheimer's disease, Parkinson's disease and progressive supranuclear palsy , 1985, Brain Research.

[49]  M. Folstein,et al.  Clinical diagnosis of Alzheimer's disease , 1984, Neurology.

[50]  Malcolm Pike,et al.  The Power Function of the “Exact” Test for Comparing Two Binomial Distributions , 1978 .